Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-24

Clinical Trial Update: Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion [Phase 4]

View source ↗

Summary

Phase 4 trial investigating denosumab's effects on bone fusion in osteoporotic patients after lumbar fusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Osteoporosis, Fusion of Spine, Lumbar Region | Phase 4 | Status: UNKNOWN